Transferring an existing mattress model to a new manufacturer requires more than simply providing a sample. You need to establish a clear, legally sound, and technically robust process to ensure the new production matches your approved model. This involves defining what can be transferred, setting measurable benchmarks, reviewing any differences in the new build, validating its performance, and controlling the first production lot. Without these steps, you risk inconsistent product quality, compliance issues, and potential intellectual property disputes.
Can the existing model legally and technically be transferred?
Before any technical work begins, you must confirm the legal and technical feasibility of transferring your mattress model. This involves a thorough inventory of your existing product's specifications, identifying what intellectual property (IP) you own or have the right to transfer, and documenting any technical information that may not be available to a new manufacturer.
Separate brand-owned specifications from restricted know-how
When transferring a mattress model, it is crucial to distinguish between specifications you own and can share, and any restricted know-how or third-party IP. This check ensures you have the legal right to authorise a new manufacturer to produce the design.
For example, using another party’s registered UK design requires a licence or ownership, and the licence terms will define permitted use. UK Intellectual Property Office (IPO) guidance differentiates licensing a registered design from assigning ownership, emphasising the need to establish transfer and use permission rather than assuming rights follow a physical sample.
To manage this, create a dated, revision-controlled record that clearly identifies the approver for each specification or design element. This record should explain what constitutes adequate evidence of ownership or permission to use, and what remains unverified. This process helps to avoid unintended IP infringement and ensures that the new manufacturer has a clear, authorised baseline to work from.

Set the reference the new factory must match
Once you have established the legal and technical basis for transfer, the next step is to translate your existing mattress model into a clear, measurable reference that the new factory must match. This involves defining objective criteria for construction, performance, and appearance, supported by physical samples where appropriate.
A signed and versioned reference sample and a written specification perform complementary roles: the sample helps communicate sensory and visual attributes, whereas the specification provides measurable tolerances and rejection rules.

For an existing mattress model transferred to AIYI, we recommend establishing a controlled Master Transfer Specification before sampling or production. This specification details key characteristics such as:
- Reference SKU: UK-HYB-200-150200
- Product: 25 cm pocket-sprung hybrid mattress
- Finished size: 150 x 200 x 25 cm
- Construction revision: BOM Rev. B03
- Reference sample: RS-UK-HYB-025, jointly approved and sealed
- Construction: 3 cm memory foam (50 ± 3 kg/m3), 2 cm transition foam (30 ± 2 kg/m3), 18 cm pocket-spring core and 2 cm supporting layers
- Net mattress weight: 32.0 ± 1.5 kg
- Finished length/width tolerance: ± 10 mm
- Finished height tolerance: ± 10 mm after 72-hour recovery under specified conditions
- Firmness target: 180 ± 20 N at the agreed indentation point, using a validated test method and conditioning protocol
- Edge support: Maximum 25 mm deflection under the agreed edge-loading test
- Packaging: Vacuum-compressed and roll-packed; Pack Rev. P02

The incoming manufacturer must demonstrate equivalent dimensions, firmness response, structural stability, material specifications, and recovery performance against this approved reference. This approach ensures that the new production can be objectively assessed against a defined standard, rather than relying on subjective comparisons.
Review the differences before approving a new build
It is rare for a new manufacturer to replicate an existing mattress model exactly, especially if they use different component suppliers or manufacturing processes. Therefore, you must systematically review any proposed differences before approving a new build.
Do not approve unseen substitutions or a nominally matching Bill of Materials (BOM) automatically. This applies when critical product attributes are governed by an approved specification. The situation changes if a rights restriction blocks transfer or a material/process difference lacks viable validation. Verification is needed through source documents, material test results, and an assessment of sample performance and compliance impact.
A manufacturing-location change is a controlled change requiring prior notification and approval, possible validation, and a defined phase-in. An industry change-control guide differentiates between an approved baseline, the impact of material, site, inspection, or packaging changes, validation before implementation, revision cut-in, and early-lot monitoring.
This review should map alternative foam grades, spring assemblies, adhesives, fire barriers, covers, and sub-suppliers against your controlled requirements. For each difference, you should log:
- The specific difference identified.
- Affected variants or components.
- Potential consequences for product performance, safety, or compliance.
- Proposed verification methods to mitigate the risk.
- The buyer's decision owner for approval or rejection.

This process helps to create a risk-ranked change register, providing a clear audit trail and preventing an unsupported promise of a clone. A component substitution can require verification even where the stated nominal specification matches, as subtle differences in material properties or processing can affect the final product.
Validate the new build against the approved model
Once potential differences have been reviewed, the new build must be validated against the approved model. This involves a proportionate sequence of technical reviews, engineering trials, samples, and applicable independent tests.
Treat a different manufacturing site as a new controlled production condition; validate affected outputs before production approval. This applies when the brand is moving a released specification or adding a second manufacturing source. The situation changes if safety-relevant construction has changed, a required property cannot be measured, or the testing scope excludes the proposed build. Verification is needed through approved criteria and reports, an understanding of the UK use case and rules, and buyer decision and deviation signatures.
For example, in a project to transfer an established UK hybrid mattress model to AIYI, initial construction comparisons showed nominal specifications matched for memory foam density, spring count, and mattress height. However, AIYI identified potential differences in foam compression behaviour, spring force response, and fabric elasticity due to different suppliers.
The proposed verification plan included:
- Approving original construction drawings, BOM revision, and reference samples.
- Performing component-level comparisons for foam properties, spring characteristics, and fabric performance.
- Producing five engineering transfer samples.
- Measuring dimensions, weight, firmness, edge support, and recovery behaviour.
- Conducting applicable durability and product-specific compliance verification.
- Submitting a controlled difference report for buyer approval.
Illustrative measured results showed that all five engineering samples met the dimensional and firmness acceptance criteria. However, the spring supplier change remained subject to component qualification and applicable durability verification. This led to a conditional approval for a controlled pilot lot, not unrestricted mass production. The buyer's technical representative approves the revised construction, while AIYI Engineering and Quality jointly authorise pilot manufacturing.

Check UK fire-safety evidence for the new construction
A critical part of validation is confirming that the new construction meets all applicable UK product fire safety requirements. This depends on the precise model construction, its intended use, and the market it will be sold into.
Does the evidence cover this construction and use? You must use a dated, revision-controlled record and name the approver. This record should explain what constitutes adequate evidence and what remains unverified.
The UK 2025 fire-safety amendment, which took effect on 30 October 2025, changed display-label rules but left applicable permanent-label obligations unaffected. Product-specific requirements must be checked against these amended rules. UK government guidance for sleeping accommodation fire risk identifies BS 7177 as a mattress/divan/bed-base resistance-to-ignition specification in its premises context. This guidance is not a universal certification mandate for all mattresses; you must confirm the intended use and the latest product-specific rules.
This distinct approval check is essential to ensure compliance and avoid market access issues.

Control the first production lot and release to supply
The final stage of transferring a mattress model is to control the first production lot and manage its release to supply. This connects all previous approvals to a frozen revision, controlled production, traceability, and a formal buyer review and decision record.
Do not release commercial supply until the agreed new-site validation and first-lot evidence are accepted. This applies when the affected SKU and process revision are identified, and mandatory checks are complete. The situation changes if open high-severity defects, incomplete rights, missing applicable compliance evidence, or uncontrolled BOM changes remain. Verification is needed through approval signatures, first-lot sample records, traceability and rework disposition, and date/site/lot cut-in.
For a first-lot transfer inspection and release, AIYI would require:
- Buyer-approved transfer sample and controlled BOM.
- First-article dimensional, weight, and firmness checks.
- In-process foam, spring assembly, and finished-product inspections.
- Compression and roll-pack verification.
- A pre-agreed finished-lot sampling plan and defect classification.
- Closure and approval of all shipment-blocking deviations.
In an illustrative scenario, if two units showed packaging-end deformation associated with inconsistent roll tension, AIYI's proposed corrective actions would include adjusting compression and rolling parameters, reinspecting the affected production interval, reworking or replacing affected packaging, and verifying corrected settings through additional consecutive packing checks. The results would be documented, and the deviation closed before shipment approval.

Agree the first-lot acceptance gate
Before any mattresses from the new production lot can be shipped, a formal acceptance gate must be passed. This ensures that all agreed conditions have been met and that the product is ready for market.
What must be signed before shipment? You must use a dated, revision-controlled record and name the approver. This record should explain what constitutes adequate evidence and what remains unverified.
AIYI recommends that the first transferred lot must not ship solely because its finished dimensions appear acceptable. Shipment release requires traceability between the approved SKU, manufacturing site, BOM revision, reference sample, verification records, deviations, corrective actions, and named final release authority. This ensures that every aspect of the transfer is documented and approved, providing a clear audit trail and accountability.
In short, transferring an existing mattress model to a new manufacturer is a complex process that demands careful attention to detail. Do not proceed without an authorised baseline, uncontrolled differences, unproven applicable safety, or an unapproved first lot. For a detailed technical and project review tailored to your specific needs, consider engaging with an OEM specialist.

0 comments